• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Danaher Corp (NY: DHR )

    276.43 +4.53 (+1.67%)
    Official Closing Price Updated: 7:00 PM EDT, Sep 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,293,978
    Open 275.44
    Bid (Size) 273.02 (1)
    Ask (Size) 282.07 (1)
    Prev. Close 271.90
    Today's Range 273.60 - 278.29
    52wk Range 182.09 - 281.70
    Shares Outstanding 724,000,000
    Dividend Yield 0.39%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Momentum Investing Gives You An Edge, Until It Doesn’t
    Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system. 
    Via Talk Markets
    Unpacking the Latest Options Trading Trends in Danaher
    Via Benzinga

    Performance

    YTD
    +17.73%
    +17.73%
    1 Month
    +1.76%
    +1.76%
    3 Month
    +11.21%
    +11.21%
    6 Month
    +8.78%
    +8.78%
    1 Year
    +22.54%
    +22.54%

    More News

    Read More
    $1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Smart Money Is Betting Big In DHR Options
    Via Benzinga
    Agilent Technologies Thrives From the Forever Chemicals Crackdown
    Via MarketBeat
    $1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
    Via Benzinga
    Behind the Scenes of Danaher's Latest Options Trends
    Via Benzinga
    $1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
    Via Benzinga
    (DHR) - Analyzing Danaher's Short Interest
    Via Benzinga
    The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
    Via Benzinga
    Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
    From Biogen Inc.
    Via GlobeNewswire
    Demystifying Danaher: Insights From 5 Analyst Reviews
    Via Benzinga
    Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
    Via Benzinga
    Top Stock Reports For Costco, Danaher & ServiceNow
    Via Talk Markets
    It's Time for Some Enthusiasm for Small-Cap Stocks
    Via The Motley Fool
    Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Here's Why Danaher Stock Surged Today
    Via The Motley Fool
    Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival
    Via Investor's Business Daily
    Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.